These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7531396

  • 1. Urinary iron speciation in nephrotic syndrome.
    Cooper MA, Buddington B, Miller NL, Alfrey AC.
    Am J Kidney Dis; 1995 Feb; 25(2):314-9. PubMed ID: 7531396
    [Abstract] [Full Text] [Related]

  • 2. Toxicity of tubule fluid iron in the nephrotic syndrome.
    Alfrey AC.
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F637-41. PubMed ID: 1384359
    [Abstract] [Full Text] [Related]

  • 3. Role of iron and oxygen radicals in the progression of chronic renal failure.
    Alfrey AC.
    Am J Kidney Dis; 1994 Feb; 23(2):183-7. PubMed ID: 8311072
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses.
    Prinsen BHCMT, Velden MGMS, Kaysen GA, Straver HWHC, Rijn HJMV, Stellaard F, Berger R, Rabelink TJ.
    J Am Soc Nephrol; 2001 May; 12(5):1017-1025. PubMed ID: 11316861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anemia in nephrotic syndrome: approach to evaluation and treatment.
    Iorember F, Aviles D.
    Pediatr Nephrol; 2017 Aug; 32(8):1323-1330. PubMed ID: 27999949
    [Abstract] [Full Text] [Related]

  • 12. Urinary iron excretion in nephrotic syndrome.
    Wiltink WF, van Eijk HG, Bobeck-Rutsaert MM, Gerbrandy J, Leijnse B.
    Acta Haematol; 1972 Aug; 47(5):269-76. PubMed ID: 4625457
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-iron mediated alteration in hepatic transferrin gene expression in the nephrotic rat.
    Kaysen GA, Sun X, Jones H, Martin VI, Joles JA, Tsukamoto H, Couser WG, al-Bander H.
    Kidney Int; 1995 Apr; 47(4):1068-77. PubMed ID: 7783403
    [Abstract] [Full Text] [Related]

  • 17. Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.
    Hall CL, Pejhan N, Terry JM, Blainey JD.
    Br Med J; 1975 Feb 22; 1(5955):419-22. PubMed ID: 803853
    [Abstract] [Full Text] [Related]

  • 18. Renal handling of the third (C3) and fourth (C4) components of the complement system in the nephrotic syndrome.
    Klajman A, Avital A, Myers BD.
    Nephron; 1976 Feb 22; 16(5):333-43. PubMed ID: 1264308
    [Abstract] [Full Text] [Related]

  • 19. Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
    Garbowski MW, Evans P, Vlachodimitropoulou E, Hider R, Porter JB.
    Haematologica; 2017 Oct 22; 102(10):1640-1649. PubMed ID: 28642302
    [Abstract] [Full Text] [Related]

  • 20. Effect of pH and citrate on binding of iron and gallium by transferrin in serum.
    McGregor SJ, Brock JH.
    Clin Chem; 1992 Sep 22; 38(9):1883-5. PubMed ID: 1526029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.